We perform a complete DNA/RNA analysis of the tumour to find new treatment options.

DNA profiling on tumour samples allows for the identification of thousands of mutations that can be linked to 780 target therapies and immunotherapies.

Our scientists and geneticists are able to advise on the most appropriate test for the specific case and perform a complete mutational analysis in less than 15 days.

Request free consultancy.
Get testing rates and conditions

    If you want you can provide further details about the clinical case by replying to the email that our clinical team will send you.

    The information transmitted is used exclusively to process your request. By submitting this form you accept the terms and conditions including our Privacy Policy. At any time you can ask for your personal data to be deleted and removed.

    This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Accept Privacy Policy

    About Oncologica

    Oncologica® is a leading precision oncology certified laboratory based in the prestigious Chesterford Research Park, Cambridge, UK. Since 2015 we have been helping oncologists and patients every day to get the maximum benefit from new advanced genetic profiling techniques for the treatment of cancer.

    “We provide cancer patients with personalised treatment options based on their unique tumour DNA profile”

    What is a genetic test on tumour sample?

    Tumours are unique because they are different kinds of DNA mutations obtained during cancer development. Therefore, treatment doesn’t work the same way for everyone. DNA profiling enables doctors to identify therapy options that are likely to offer the most successful outcomes. This evolution of DNA profiling has enabled the use of an individual’s DNA profile to target particular mutations in cancer.

    Our testing options available for cancer patients:

    The world’s most comprehensive precision oncology test which is able to match the unique genetic profile of the tumour to the most appropriate targeted therapies on the basis of the highest clinical evidenze available.
    Test for the evaluation of tumour mutational burden to predict response to immunotherapy.
    Analysis of PD-L1 expression to predict which patients are likely to respond to PD-1/PD-L1 directed immunotherapies.

    Which types of tumours are eligible for DNA testing
    and correlation to the best targeted therapies?

    • bladder cancer
    • brain cancer
    • breast cancer
    • colon cancer
    • kidney cancer
    • liver cancer
    • lung cancer
    • melanoma
    • neck cancer
    • ovarian cancer
    • pancreatic cancer
    • prostate cancer
    • skin cancer
    • stomach cancer
    • uterine cancer

    .. AND 100+ SOLID TUMOUR TYPES

    Read patient stories and reviews on

    A great team of genetists, phatologist and oncologists to
    help you and your doctor to find a tailored theraphy.

    Dr Marco Loddo
    CO-FOUNDER AND SCIENTIFIC DIRECTOR

    BSc PhD
    Keeda-Marie Hardisty
    LEAD CLINICAL SCIENTIST

    BSc
    Keeley Monsen
    LABORATORY AND QUALITY MANAGER

    BSc

    Can Oncofocus Test help me? Get a free advice today!

    Book a free consultation call with our Clinical Team to obtain more information on suitability for testing.

    Oncologica® UK ltd.
    Suite 15-16 The Science Village, Chesterford Research Park, Little Chesterford, Cambridge, CB10 1XL
    +44 (0) 1223 785327